Concomitant inactivation of the p53- and pRB- functional pathways predicts resistance to DNA damaging drugs in breast cancer in vivo-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Concomitant inactivation of the p53- and pRB- functional pathways predicts resistance to DNA damaging drugs in breast cancer in vivo

Published:2015-05-08 Issue:8 Volume:9 Page:1553-1564
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:

Author:

Knappskog Stian,Berge Elisabet O.,Chrisanthar Ranjan,Geisler Stephanie,Staalesen Vidar,Leirvaag Beryl,Yndestad Synnøve,de Faveri Elise,Karlsen Bård O.,Wedge David C.,Akslen Lars A.,Lilleng Peer K.,Løkkevik Erik,Lundgren Steinar,Østenstad Bjørn,Risberg Terje,Mjaaland Ingvild,Aas Turid,Lønning Per E.

Funder

Bergen Medical Research Foundation

Norwegian Cancer Society

Norwegian Health Region West

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1016/j.molonc.2015.04.008/fullpdf

Reference49 articles.

1. Multicenter randomized trial comparing sequential with concomitant administration of doxorubicin and docetaxel as first-line treatment of metastatic breast cancer: a Spanish Breast Cancer Research Group (GEICAM-9903) phase III study;Alba;J. Clin. Oncol,2004

2. Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial;Albain;Lancet Oncol,2010

3. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100000 women in 123 randomised trials;Albain;Lancet,2012

4. Identification and characterization of retinoblastoma gene mutations disturbing apoptosis in human breast cancers;Berge;Mol. Cancer,2010

5. Alterations of the retinoblastoma gene in metastatic breast cancer;Berge;Clin. Exp. Metastasis,2011

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atypical responses to neoadjuvant chemotherapy combined with accelerated partial breast tumor-directed radiotherapy: two cases and considerations for future clinical trials;Reports of Practical Oncology and Radiotherapy;2022-12-29

2. DNA damage response signaling pathways as important targets for combination therapy and chemotherapy sensitization in osteosarcoma;Journal of Cellular Physiology;2022-04-05

3. TP53 inhibitor PFTα increases the sensitivity of arsenic trioxide in TP53 wildtype tumor cells;FEBS Open Bio;2022-01-26

4. High‐throughput CRISPR‐mediated 3D enrichment platform for functional interrogation of chemotherapeutic resistance;Biotechnology and Bioengineering;2021-06-06

5. Genetic Predictors of Malignancy: a Literature Review;Creative surgery and oncology;2021-05-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3